负荷心脏磁共振缺血负荷与心血管事件:ISCHEMIA试验的事后分析
在ISCHEMIA试验3909例随机患者中,比较负荷心脏磁共振(CMR,n=313)与SPECT/负荷超声(n=5627)对缺血严重程度的预后价值。中位随访3.37年,CMR核心实验室判定的缺血严重程度与主要终点累积4年事件率相关(P=0.042),而SPECT/超声缺血严重程度无此关联。校正年龄、eGFR和糖尿病后,CMR每增加一个缺血节段主要终点风险增加13%(交互P=0.02)。
要点
- CMR判定的无/轻度、中度、重度缺血4年主要终点事件率分别为0%、14%、23%,SPECT/超声分别为18%、15%、16%。
- CMR缺血严重程度与主要终点(P=0.042)、心血管死亡/MI(P=0.041)和非致死性MI(P=0.03)相关,SPECT/超声无此关联。
- 初始保守治疗且无/轻度缺血者,CMR组4年侵入性转诊率和血运重建率低于SPECT/超声组(16.7%和0% vs 31%和13.3%)。
核心结论
- CMR判定的缺血严重程度与ISCHEMIA试验所有终点的关联强于SPECT/负荷超声。
研究设计与样本
- ISCHEMIA试验的事后分析,纳入3909例随机患者,比较CMR(n=313)与SPECT/负荷超声(n=5627)的预后价值。
- 以CMR或SPECT/超声测量的缺血和梗死范围,关联主要终点(心血管死亡、非致死性MI、不稳定心绞痛住院、心衰住院或复苏性心脏骤停),中位随访3.37年(Q1-Q3:2.20-4.56年)。
诊断标准与关键数值
- CMR核心实验室判定的无/轻度、中度、重度缺血4年主要终点事件率分别为0%、14%、23%;SPECT/超声分别为18%、15%、16%。
- CMR缺血严重程度与主要终点(P=0.042)、心血管死亡/MI(P=0.041)、非致死性MI(P=0.03)相关;SPECT/超声缺血严重程度与上述终点均无显著关联。
- 校正年龄、eGFR和糖尿病后,CMR每增加一个缺血节段主要终点风险增加13%(交互P=0.02)。
临床应用与阅片要点
- 与SPECT/超声相比,CMR参与者重度缺血比例更高(57% vs 38%,P<0.001),随机化比例更高(82% vs 65%,P<0.001)。
- 初始保守治疗且无/轻度缺血者,CMR组4年侵入性转诊率和血运重建率低于SPECT/超声组(16.7%和0% vs 31%和13.3%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Research comparing the prognostic value of stress cardiac magnetic resonance (CMR) to other stress modalities in patients with coronary disease is limited.
OBJECTIVES: The authors compared the prognostic value of stress CMR vs alternative testing by either single-photon emission computed tomography or stress echocardiography (SPECT/echo) in the ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial.
METHODS: CMR vs SPECT/echo was compared in 3,909 patients randomized in ISCHEMIA after sites' interpretation of moderate to severe ischemia. Ischemia and infarct extent, measured by either CMR or SPECT/echo, were each associated with the trial's primary outcome of cardiovascular death, nonfatal myocardial infarction (MI), or hospitalization for unstable angina, heart failure, or resuscitated cardiac arrest, at a median follow-up of 3.37 years (Q1-Q3: 2.20-4.56 years).
RESULTS: Compared with SPECT/echo (n = 5,627), CMR participants (n = 313) were not different in key demographic factors but were more likely to have severe ischemia (57% vs 38%; P < 0.001) and to be randomized (n = 257, 82%, vs n = 3,652, 65%; P < 0.001). Ischemia severity (no/mild, moderate, severe) by CMR core laboratory was associated with cumulative 4-year event rates of all trial-specific endpoints, including the primary outcome (P = 0.042), cardiovascular death/MI (P = 0.041), and nonfatal MI (P = 0.03), but SPECT/echo ischemia severity was not. No/mild, moderate, and severe ischemia by CMR were associated with 0%, 14%, and 23% 4-year primary outcome rates, respectively, compared with 18%, 15%, and 16%, by SPECT/echo. After adjustment for age, estimated glomerular filtration rate, and diabetes, the association between ischemia extent and the primary endpoint differed by imaging modality, with each additional ischemic segment on CMR associated with a 13% increase in hazard (interaction P = 0.02). In participants assigned to initial conservative management who had no/mild ischemia on imaging, 4-year rates of invasive referral and coronary revascularization were lower in the CMR than SPECT/echo group (16.7% and 0%, respectively, for CMR; and 31% and 13.3%, respectively, for SPECT/echo).
CONCLUSIONS: Ischemia severity by CMR had a stronger association with all ISCHEMIA trial endpoints compared with SPECT/echo. (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches [ISCHEMIA]; NCT01471522).
引用
- Kwong RY, Heydari B, Abbasi S, et al. Stress Cardiac Magnetic Resonance Ischemia Burden and Cardiovascular Events: Post-Hoc Analysis From the ISCHEMIA Trial. JACC Cardiovasc Imaging. 2025. PMID: 41351610. doi:10.1016/j.jcmg.2025.10.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。